
Structured lifestyle program improves quality of life for men on prostate cancer therapy
A UK randomized trial of 700 men on androgen deprivation therapy for prostate cancer found that the STAMINA program—supervised exercise, dietary guidance, and behavioral support—reduced deterioration in cancer-specific quality of life by up to one-third and lessened fatigue; the regimen was cost-effective and feasible within NHS trusts, with high attendance, and prompted Nuffield Health to plan broader rollout, including expansion to other cancers by 2030, though long-term survival effects remain unknown.
